Abstract

A three day event discussing aspects of vaccine development and vaccinations.

This year there are three main topics for discussion Next Generation Vaccines:

• Adjuvants and delivery systems
• Advances in overcoming co-infections
• The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination

With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding vaccines and vaccination.

This event has an open poster session. Posters can be submitted on any subject related to vaccines and vaccination

This event has CPD accreditation

Who Should Attend Public and animal health scientists Scientists developing, or with an interest in, new or enhanced vaccine adjuvants Individuals interested in novel vaccine delivery systems Individuals establishing diagnostic assays for viruses. Epidemiologists, virologists, immunologists, R&D, pre-clinical vaccinologists Basic scientists, industrial experts, and clinicians with an interest in the science of viral co-infection.

The deadline for abstract submissions for oral presentation is August 10th 2014 Abstracts for poster presentation only can be submitted up to two weeks before the event . You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf

Program Outline

• Day 1: Next Generation Vaccines: Adjuvants and delivery systems This session will discuss current research into the development of new or enhanced adjuvants and novel delivery systems which are widely accepted as key to creating more efficacious vaccines with improved methods for storage and delivery. Session Chair: To be confirmed Morning Poster Session: Vaccine Adjuvants Afternoon Poster Session: Vaccine Delivery Systems

• Day 2: Advances in overcoming co-infections The advent of effective combination antiretroviral therapy has made living with, rather than dying from HIV -1 infection a reality. Now, an ageing HIV -1 seropositive population are living with co-infection by pathogens for which effective treatments remain in development. As the effort to develop prophylactic or therapeutic vaccines continue, the aim of this session will highlight advances in the science of pathogens commonly found as co-infections in people living with HIV . Session Chair: Christopher JK Ward, Innate Immune Sensors Group Institute of Infection & Immunity Cardiff University School of Medicine Morning Poster Session: Research in overcoming co -infections Afternoon Poster Session: Open poster session.

• Day 3: The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination The switching of surface envelope proteins expressed on the surface of pseudotype viruses enables them to be used as surrogate viruses in neutralization/antiviral screening assays and for the study of cell–virus receptor interactions. This day will discuss ongoing research, assay development and applications of the using pseudotype viruses for virus detection and vaccination.

Morning Session Human virus pseudotypes. Chair: Dr Nigel Temperton, Senior Lecturer, University of Kent, UK

Afternoon Session Animal virus pseudotypes. Chair: Dr Simon Scott, University of Kent, UK

Morning Poster Session: Human virus pseudotype Afternoon Poster Session: Animal virus pseudotypes.